ROBYN NAMENDORF: Open Payments
NPI 1639945595 · MARTINSBURG, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$607 in 18 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $338 · 2025 $607
Food & beverage: $607
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 1 | $108 |
| Amgen Inc. | 1 | $103 |
| Otsuka America Pharmaceutical, Inc. | 1 | $102 |
| ABBVIE INC. | 4 | $75 |
| Lundbeck LLC | 3 | $67 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $52 |
| Alkermes, Inc. | 2 | $34 |
| Teva Pharmaceuticals USA, Inc. | 2 | $32 |
| Neurocrine BioSciences, Inc. | 1 | $21 |
| Axsome Therapeutics, Inc. | 1 | $14 |
Products named: REXULTI, FANAPT, REPATHA, VRAYLAR, CAPLYTA, ARISTADA, AUSTEDO XR, INGREZZA.
Industry payments across WV — which companies pay providers there.
